The efficacy and safety of abrocitinib in atopic dermatitis patients after switching from dupilumab was investigated where researchers analyzed data from patients who were initially enrolled in the JADE COMPARE study, comparing dupilumab versus abrocitinib.
The Efficacy of Abrocitinib After Dupilumab
